Literature DB >> 20028367

Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver.

Zhigang Wang1, Tong Yao, Zhenyuan Song.   

Abstract

BACKGROUND: Chronic alcohol consumption causes alcoholic liver disease, which is associated, or initiated, with dysregulated lipid metabolism. Very recent evidence suggested that dysregulated cholesterol metabolism plays an important role in the pathogenesis of alcoholic fatty liver diseases, however, the effects of chronic alcohol exposure on cholesterol homeostasis have not been well studied and underlying mechanisms behind are still elusive.
METHODS: Male Sprague-Dawley rats weighing 250 +/- 5.5 g (mean +/- SEM) divided into 2 groups (8 rats per group) and pair-fed with liquid diets containing (in percent of energy intake) 18% protein, 35% fat, 12% carbohydrate, and 35% either ethanol (ethanol diet) or an isocaloric maltose-dextrin mixture (control diet), according to Lieber and De Carli, for 4 weeks.
RESULTS: Long-term excessive alcohol feeding to rats caused fatty liver and liver injury, which was associated with disrupted cholesterol homeostasis, characterized by increased hepatic cholesterol levels and hypercholesterolemia. Hepatic cholesterol increases were concomitant with constantly activated sterol regulatory element-binding protein-2 (SREBP-2) in the liver and increased expression of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, a rate-limiting enzyme for cholesterol de novo synthesis, indicating enhanced cholesterol biosynthesis. Alcohol-induced hypercholesterolemia was accompanied by decreased LDL receptor (LDLr) levels in the liver. Further investigations revealed that chronic alcohol exposure increased hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) contents to down-regulate LDLr via a post-translational mechanism. Moreover, alcohol feeding suppressed extracellular signal-regulated kinase (ERK) activation in the liver. In vitro studies showed that inhibition of ERK activation was associated with decreased LDLr expression in HepG2 cells.
CONCLUSIONS: Our study provides the first evidence that both increased PCSK9 expression and suppressed ERK activation in the liver contributes to alcohol-induced hypercholesterolemia in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028367      PMCID: PMC3260025          DOI: 10.1111/j.1530-0277.2009.01111.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  35 in total

Review 1.  Cholesterol sensing, trafficking, and esterification.

Authors:  Ta-Yuan Chang; Catherine C Y Chang; Nobutaka Ohgami; Yoshio Yamauchi
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 2.  Dual regulation of the LDL receptor--some clarity and new questions.

Authors:  Alan D Attie; Nabil G Seidah
Journal:  Cell Metab       Date:  2005-05       Impact factor: 27.287

3.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

Review 4.  SREBP transcription factors: master regulators of lipid homeostasis.

Authors:  Delphine Eberlé; Bronwyn Hegarty; Pascale Bossard; Pascal Ferré; Fabienne Foufelle
Journal:  Biochimie       Date:  2004-11       Impact factor: 4.079

5.  Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.

Authors:  Bettina König; Alexander Koch; Julia Spielmann; Christian Hilgenfeld; Gabriele I Stangl; Klaus Eder
Journal:  Biochem Pharmacol       Date:  2006-11-10       Impact factor: 5.858

6.  Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.

Authors:  Parveen Abidi; Yue Zhou; Jian-Dong Jiang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-11       Impact factor: 8.311

7.  Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.

Authors:  Kristiaan Wouters; Patrick J van Gorp; Veerle Bieghs; Marion J Gijbels; Hans Duimel; Dieter Lütjohann; Anja Kerksiek; Roger van Kruchten; Nobuyo Maeda; Bart Staels; Marc van Bilsen; Ronit Shiri-Sverdlov; Marten H Hofker
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

Review 8.  PCSK9: an enigmatic protease.

Authors:  Dayami Lopez
Journal:  Biochim Biophys Acta       Date:  2008-02-02

Review 9.  Alcohol-induced steatosis in liver cells.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 10.  Cholesterol and sphingolipids in alcohol-induced liver injury.

Authors:  Anna Fernández; Anna Colell; Carmen Garcia-Ruiz; José C Fernandez-Checa
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

View more
  32 in total

1.  Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.

Authors:  Dwight R Stickney; Clarence N Ahlem; Elizabeth Morgan; Christopher L Reading; Nanette Onizuka; James M Frincke
Journal:  Am J Transl Res       Date:  2011-04-12       Impact factor: 4.060

2.  Differential effects of daily-moderate versus weekend-binge alcohol consumption on atherosclerotic plaque development in mice.

Authors:  Weimin Liu; Eileen M Redmond; David Morrow; John P Cullen
Journal:  Atherosclerosis       Date:  2011-08-30       Impact factor: 5.162

3.  FGF receptor antagonism does not affect adipose tissue development in nutritionally induced obesity.

Authors:  Ilse Scroyen; Christine Vranckx; Henri Roger Lijnen
Journal:  Adipocyte       Date:  2013-12-11       Impact factor: 4.534

4.  Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration.

Authors:  Rachael P Dippold; Rajanikanth Vadigepalli; Gregory E Gonye; Biswanath Patra; Jan B Hoek
Journal:  Alcohol Clin Exp Res       Date:  2012-07-23       Impact factor: 3.455

5.  Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.

Authors:  Zhigang Wang; Tong Yao; Zhenyuan Song
Journal:  J Lipid Res       Date:  2010-08-25       Impact factor: 5.922

6.  Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Authors:  Annayya R Aroor; Shivendra D Shukla
Journal:  World J Hepatol       Date:  2011-09-27

7.  Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.

Authors:  Mashiko Setshedi; Lisa Longato; Dennis R Petersen; Martin Ronis; William C Chen; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

8.  Extracellular signal-regulated kinases 1/2 suppression aggravates transforming growth factor-beta1 hepatotoxicity: a potential mechanism for liver injury in methionine-choline deficient-diet-fed mice.

Authors:  Zhigang Wang; Tong Yao; Zhenyuan Song
Journal:  Exp Biol Med (Maywood)       Date:  2010-10-20

9.  Histone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanol.

Authors:  Taryn T James; Annayya R Aroor; Robert W Lim; Shivendra D Shukla
Journal:  J Pharmacol Exp Ther       Date:  2011-10-24       Impact factor: 4.030

10.  Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder.

Authors:  Daniel B Rosoff; Katrin Charlet; Jeesun Jung; Jisoo Lee; Christine Muench; Audrey Luo; Martha Longley; Falk W Lohoff
Journal:  Alcohol       Date:  2020-04-23       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.